Latest Breaking News On - Pharmacy benefit management - Page 1 : comparemela.com

Pharmacy Benefit Management Market Poised for USD 882 Billion

Leerink Partners Downgrades CVS Health to Market Perform From Outperform, Adjusts PT to $60 From $87

CVS Health has an average rating of outperform and price targets ranging from $60 to $103, according to analysts polled by Capital IQ. Price: 56.50, Change: -11.21, Percent Change: -16.56 .

Evercore ISI Cuts CVS Health's Price Target to $65 From $85

CVS Health has an average rating of outperform and price targets ranging from $60 to $103, according to analysts polled by Capital IQ. Price: 55.40, Change: -12.31, Percent Change: -18.18 .

Genetic Testing and Risk Assessments for Opioid Use Disorder (OUD)

Genetic Testing and Risk Assessments for Opioid Use Disorder (OUD) | Workerscompensation.com

The US Pharmacy Benefit Management Market to Reach $680 Billion by 2029, Growing at a CAGR of 5.56%

/PRNewswire/ According to the latest research report, the US pharmacy benefit management market is growing at a CAGR of 5.56% during 2023-2029. To Know.